Clinical trial · Interventional
BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The central goal of this study is to test strategies to implement evidence-based breast cancer risk assessment in healthcare clinics in Tennessee. The BRAVE Strategy (Breast cancer Risk Assessment - achieVing Equity) study aims to assess the feasibility, reach, acceptability, and appropriateness of select customized strategies to increase uptake of breast cancer risk assessment. The investigators will achieve these aims through a conducting a stepped-wedge trial conducted in 10 healthcare clinics in the state of Tennessee. The primary outcome is the proportion of women age 25-49 having risk assessment. Secondary outcomes include the numbers of 1) women identified as high-risk; 2) pursuing risk-adherent screening; and 3) diagnosed with breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intervention plus 10 months maintenance | Other | — | UNRESOLVED |
| Intervention plus 12 months maintenance | Other | — | UNRESOLVED |
| Intervention plus 4 months maintenance | Other | — | UNRESOLVED |
| Intervention plus 6 months maintenance | Other | — | UNRESOLVED |
| Intervention plus 8 months maintenance | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (5)
- type
- EXPERIMENTAL
- label
- Intervention plus 12 months maintenance
- description
- Clinics in this group will be in the control phase for 2 months, receive the 4 month intervention, and be in the maintenance phase for 12 months.
- interventionNames
- Other: Intervention plus 12 months maintenance
- type
- EXPERIMENTAL
- label
- Intervention plus 10 months maintenance
- description
- Clinics in this group will be in the control phase for 4 months, receive the 4 month intervention, and be in the maintenance phase for 10 months.
- interventionNames
- Other: Intervention plus 10 months maintenance
- type
- EXPERIMENTAL
- label
- Intervention plus 8 months maintenance
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 49 Years
Show eligibility criteria text
Inclusion Criteria: * ages 25-49 Exclusion Criteria: * personal history of breast cancer
References
Publications (0)
Data not yet available